(89) Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma: Results from phase 3 ZIRCON study Meeting Abstract
| Authors: | Shuch, B. M.; Pantuck, A. J.; Bernhard, J. C.; Morris, M.; Master, V. A.; Scott, A. M.; Van Praet, C.; Bailly, C.; Onal, B.; Aksoy, T.; Merkx, R.; Schuster, D. M.; Lee, S. T.; Pandit-Taskar, N.; Fan, A. C.; Tauchmanova, L.; Schmidt, K.; Vadali, K.; Hayward, C.; Mulders, P. |
| Abstract Title: | (89) Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma: Results from phase 3 ZIRCON study |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.4554 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 4554 -- This meeting was also held virtually -- Source: Cinahl |
